Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Mol Cancer Ther. 2009 Apr;8(4):893–903. doi: 10.1158/1535-7163.MCT-08-1078

Figure 4.

Figure 4

Effect of cisplatin and TW-37 on apoptosis and cell cycle of endothelial or head and neck tumor cells. A, Cells were exposed to cisplatin and/or TW-37. After 72 hours, cells were stained with propidium iodide and subjected to flow cytometry for the analysis of the proportion of apoptotic cells (sub-G0/G1). Asterisk (*) depicts that the combination regimen is significantly higher than any of the single drug (cisplatin or TW-37) regimen by itself (P<0.05). B, Cells were treated as in panel A, stained with propidium iodide, and the percentage of cells in each cell cycle phase was determined by flow cytometry. Representative of at least three independent experiments performed in triplicate wells per condition.